주사 약물전달 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Injectable Drug Delivery Market - Scope of Report

TMR's report on the global injectable drug delivery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global injectable drug delivery market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global injectable drug delivery market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the injectable drug delivery market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global injectable drug delivery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global injectable drug delivery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global injectable drug delivery market.

The report delves into the competitive landscape of the global injectable drug delivery market. Key players operating in the global injectable drug delivery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global injectable drug delivery market profiled in this report.

Key Questions Answered in Global injectable drug delivery Market Report:

• What is the sales/revenue generated by injectable drug delivery across all regions during the forecast period?
• What are the opportunities in the global injectable drug delivery market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Injectable Drug Delivery Market - Research Objectives and Research Approach

The comprehensive report on the global injectable drug delivery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global injectable drug delivery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global injectable drug delivery market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Injectable Drug Delivery Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Injectable Drug Delivery Market Analysis and Forecasts, 2020-2034
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. PEST Analysis
• 5.2. Product Launches and Approvals
• 5.3. Regulatory Landscape for Injectable Drug Delivery in Key Regions / Countries
• 5.4. FDA Drug Approval Process
• 5.5. Key Industry Events (Acquisition, Partnerships, And Collaborations)

6. Global Injectable Drug Delivery Market Analysis and Forecasts, By Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Product Type, 2020-2034
  • 6.3.1. Devices
    • 6.3.1.1. Conventional Injection Devices
    • 6.3.1.2. Self Injection Devices
    • 6.3.1.3. Others
  • 6.3.2. Formulations
    • 6.3.2.1. Conventional Drug Delivery Formulations
    • 6.3.2.2. Novel Drug Delivery Formulations
    • 6.3.2.3. Long Lasting Injection Formulations
• 6.4. Market Attractiveness By Product Type

7. Global Injectable Drug Delivery Market Analysis and Forecasts, By Therapeutic Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Therapeutic Application, 2020-2034
  • 7.3.1. Autoimmune Disease
  • 7.3.2. Hormone Disease
  • 7.3.3. Orphan Disease
  • 7.3.4. Cancer
  • 7.3.5. Cardiovascular Disease
  • 7.3.6. Infectious Disease
  • 7.3.7. Others
• 7.4. Market Attractiveness By Therapeutic Application

8. Global Injectable Drug Delivery Market Analysis and Forecasts, By Usage Pattern

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Usage Pattern, 2020-2034
  • 8.3.1. Curative Care
  • 8.3.2. Immunization
  • 8.3.3. Others
• 8.4. Market Attractiveness By Usage Pattern

9. Global Injectable Drug Delivery Market Analysis and Forecasts, By End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By End-user, 2020-2034
  • 9.3.1. Hospitals and Clinics
  • 9.3.2. Ambulatory Surgical Centers
  • 9.3.3. Home Care Settings
  • 9.3.4. Others
• 9.4. Market Attractiveness By End-user

10. Global Injectable Drug Delivery Market Analysis and Forecasts, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Country/Region

11. North America Injectable Drug Delivery Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Product Type, 2020-2034
  • 11.2.1. Devices
    • 11.2.1.1. Conventional Injection Devices
    • 11.2.1.2. Self Injection Devices
    • 11.2.1.3. Others
  • 11.2.2. Formulations
    • 11.2.2.1. Conventional Drug Delivery Formulations
    • 11.2.2.2. Novel Drug Delivery Formulations
    • 11.2.2.3. Long Lasting Injection Formulations
• 11.3. Market Value Forecast By Therapeutic Application, 2020-2034
  • 11.3.1. Autoimmune Disease
  • 11.3.2. Hormone Disease
  • 11.3.3. Orphan Disease
  • 11.3.4. Cancer
  • 11.3.5. Cardiovascular Disease
  • 11.3.6. Infectious Disease
  • 11.3.7. Others
• 11.4. Market Value Forecast By Usage Pattern, 2020-2034
  • 11.4.1. Curative Care
  • 11.4.2. Immunization
  • 11.4.3. Others
• 11.5. Market Value Forecast By End-user, 2020-2034
  • 11.5.1. Hospitals and Clinics
  • 11.5.2. Ambulatory Surgical Centers
  • 11.5.3. Home Care Settings
  • 11.5.4. Others
• 11.6. Market Value Forecast By Country, 2020-2034
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product Type
  • 11.7.2. By Therapeutic Application
  • 11.7.3. By Usage Pattern
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Injectable Drug Delivery Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Product Type, 2020-2034
  • 12.2.1. Devices
    • 12.2.1.1. Conventional Injection Devices
    • 12.2.1.2. Self Injection Devices
    • 12.2.1.3. Others
  • 12.2.2. Formulations
    • 12.2.2.1. Conventional Drug Delivery Formulations
    • 12.2.2.2. Novel Drug Delivery Formulations
    • 12.2.2.3. Long Lasting Injection Formulations
• 12.3. Market Value Forecast By Therapeutic Application, 2020-2034
  • 12.3.1. Autoimmune Disease
  • 12.3.2. Hormone Disease
  • 12.3.3. Orphan Disease
  • 12.3.4. Cancer
  • 12.3.5. Cardiovascular Disease
  • 12.3.6. Infectious Disease
  • 12.3.7. Others
• 12.4. Market Value Forecast By Usage Pattern, 2020-2034
  • 12.4.1. Curative Care
  • 12.4.2. Immunization
  • 12.4.3. Others
• 12.5. Market Value Forecast By End-user, 2020-2034
  • 12.5.1. Hospitals and Clinics
  • 12.5.2. Ambulatory Surgical Centers
  • 12.5.3. Home Care Settings
  • 12.5.4. Others
• 12.6. Market Value Forecast By Country, 2020-2034
  • 12.6.1. Germany
  • 12.6.2. U.K.
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product Type
  • 12.7.2. By Therapeutic Application
  • 12.7.3. By Usage Pattern
  • 12.7.4. By End-user
  • 12.7.5. By Country

13. Asia Pacific Injectable Drug Delivery Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Product Type, 2020-2034
  • 13.2.1. Devices
    • 13.2.1.1. Conventional Injection Devices
    • 13.2.1.2. Self Injection Devices
    • 13.2.1.3. Others
  • 13.2.2. Formulations
    • 13.2.2.1. Conventional Drug Delivery Formulations
    • 13.2.2.2. Novel Drug Delivery Formulations
    • 13.2.2.3. Long Lasting Injection Formulations
• 13.3. Market Value Forecast By Therapeutic Application, 2020-2034
  • 13.3.1. Autoimmune Disease
  • 13.3.2. Hormone Disease
  • 13.3.3. Orphan Disease
  • 13.3.4. Cancer
  • 13.3.5. Cardiovascular Disease
  • 13.3.6. Infectious Disease
  • 13.3.7. Others
• 13.4. Market Value Forecast By Usage Pattern, 2020-2034
  • 13.4.1. Curative Care
  • 13.4.2. Immunization
  • 13.4.3. Others
• 13.5. Market Value Forecast By End-user, 2020-2034
  • 13.5.1. Hospitals and Clinics
  • 13.5.2. Ambulatory Surgical Centers
  • 13.5.3. Home Care Settings
  • 13.5.4. Others
• 13.6. Market Value Forecast By Country, 2020-2034
  • 13.6.1. China
  • 13.6.2. India
  • 13.6.3. Japan
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product Type
  • 13.7.2. By Therapeutic Application
  • 13.7.3. By Usage Pattern
  • 13.7.4. By End-user
  • 13.7.5. By Country

14. Latin America Injectable Drug Delivery Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Product Type, 2020-2034
  • 14.2.1. Devices
    • 14.2.1.1. Conventional Injection Devices
    • 14.2.1.2. Self Injection Devices
    • 14.2.1.3. Others
  • 14.2.2. Formulations
    • 14.2.2.1. Conventional Drug Delivery Formulations
    • 14.2.2.2. Novel Drug Delivery Formulations
    • 14.2.2.3. Long Lasting Injection Formulations
• 14.3. Market Value Forecast By Therapeutic Application, 2020-2034
  • 14.3.1. Autoimmune Disease
  • 14.3.2. Hormone Disease
  • 14.3.3. Orphan Disease
  • 14.3.4. Cancer
  • 14.3.5. Cardiovascular Disease
  • 14.3.6. Infectious Disease
  • 14.3.7. Others
• 14.4. Market Value Forecast By Usage Pattern, 2020-2034
  • 14.4.1. Curative Care
  • 14.4.2. Immunization
  • 14.4.3. Others
• 14.5. Market Value Forecast By End-user, 2020-2034
  • 14.5.1. Hospitals and Clinics
  • 14.5.2. Ambulatory Surgical Centers
  • 14.5.3. Home Care Settings
  • 14.5.4. Others
• 14.6. Market Value Forecast By Country, 2020-2034
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product Type
  • 14.7.2. By Therapeutic Application
  • 14.7.3. By Usage Pattern
  • 14.7.4. By End-user
  • 14.7.5. By Country

15. Middle East & Africa Injectable Drug Delivery Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Product Type, 2020-2034
  • 15.2.1. Devices
    • 15.2.1.1. Conventional Injection Devices
    • 15.2.1.2. Self Injection Devices
    • 15.2.1.3. Others
  • 15.2.2. Formulations
    • 15.2.2.1. Conventional Drug Delivery Formulations
    • 15.2.2.2. Novel Drug Delivery Formulations
    • 15.2.2.3. Long Lasting Injection Formulations
• 15.3. Market Value Forecast By Therapeutic Application, 2020-2034
  • 15.3.1. Autoimmune Disease
  • 15.3.2. Hormone Disease
  • 15.3.3. Orphan Disease
  • 15.3.4. Cancer
  • 15.3.5. Cardiovascular Disease
  • 15.3.6. Infectious Disease
  • 15.3.7. Others
• 15.4. Market Value Forecast By Usage Pattern, 2020-2034
  • 15.4.1. Curative Care
  • 15.4.2. Immunization
  • 15.4.3. Others
• 15.5. Market Value Forecast By End-user, 2020-2034
  • 15.5.1. Hospitals and Clinics
  • 15.5.2. Ambulatory Surgical Centers
  • 15.5.3. Home Care Settings
  • 15.5.4. Others
• 15.6. Market Value Forecast By Country, 2020-2034
  • 15.6.1. GCC
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product Type
  • 15.7.2. By Therapeutic Application
  • 15.7.3. By Usage Pattern
  • 15.7.4. By End-user
  • 15.7.5. By Country

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis By Company (2021)
• 16.3. Market Footprint Analysis
  • 16.3.1. By Region
  • 16.3.2. By Product Type
• 16.4. Competitive Business Strategies
• 16.5. Company Profiles
  • 16.5.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.5.2. Market Share Analysis, by Company (2023)
  • 16.5.3. Company Profiles
    • 16.5.3.1. Becton, Dickinson, and Company (BD)
      • 16.5.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.1.2. Product Portfolio
      • 16.5.3.1.3. Financial Overview
      • 16.5.3.1.4. SWOT Analysis
      • 16.5.3.1.5. Strategic Overview
    • 16.5.3.2. Pfizer, Inc.
      • 16.5.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.2.2. Product Portfolio
      • 16.5.3.2.3. Financial Overview
      • 16.5.3.2.4. SWOT Analysis
      • 16.5.3.2.5. Strategic Overview
    • 16.5.3.3. Eli Lilly and Company
      • 16.5.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.3.2. Product Portfolio
      • 16.5.3.3.3. Financial Overview
      • 16.5.3.3.4. SWOT Analysis
      • 16.5.3.3.5. Strategic Overview
    • 16.5.3.4. Baxter International, Inc.
      • 16.5.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.4.2. Product Portfolio
      • 16.5.3.4.3. Financial Overview
      • 16.5.3.4.4. SWOT Analysis
      • 16.5.3.4.5. Strategic Overview
    • 16.5.3.5. Terumo Corporation
      • 16.5.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.5.2. Product Portfolio
      • 16.5.3.5.3. Financial Overview
      • 16.5.3.5.4. SWOT Analysis
      • 16.5.3.5.5. Strategic Overview
    • 16.5.3.6. B. Braun Melsungen AG
      • 16.5.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.6.2. Product Portfolio
      • 16.5.3.6.3. Financial Overview
      • 16.5.3.6.4. SWOT Analysis
      • 16.5.3.6.5. Strategic Overview
    • 16.5.3.7. Ypsomed AG
      • 16.5.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.7.2. Product Portfolio
      • 16.5.3.7.3. Financial Overview
      • 16.5.3.7.4. SWOT Analysis
      • 16.5.3.7.5. Strategic Overview
    • 16.5.3.8. Gerresheimer AG
      • 16.5.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.8.2. Product Portfolio
      • 16.5.3.8.3. Financial Overview
      • 16.5.3.8.4. SWOT Analysis
      • 16.5.3.8.5. Strategic Overview
    • 16.5.3.9. SCHOTT Pharma
      • 16.5.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.9.2. Product Portfolio
      • 16.5.3.9.3. Financial Overview
      • 16.5.3.9.4. SWOT Analysis
      • 16.5.3.9.5. Strategic Overview
    • 16.5.3.10. Hi-Tech Syringes
      • 16.5.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.5.3.10.2. Product Portfolio
      • 16.5.3.10.3. Financial Overview
      • 16.5.3.10.4. SWOT Analysis
      • 16.5.3.10.5. Strategic Overview